↓ Skip to main content

Receptor–ligand pair typing and prognostic risk model of response or resistance to immune checkpoint inhibitors in lung adenocarcinoma

Overview of attention for article published in Frontiers in oncology, April 2023
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (58th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter
4 X users

Readers on

mendeley
12 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Receptor–ligand pair typing and prognostic risk model of response or resistance to immune checkpoint inhibitors in lung adenocarcinoma
Published in
Frontiers in oncology, April 2023
DOI 10.3389/fonc.2023.1170942
Pubmed ID
Authors

Shengqiang Mao, Lingyan Zeng, Ying Yang, Zhiqiang Liu, Li Zhang

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 12 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 17%
Lecturer > Senior Lecturer 2 17%
Student > Master 1 8%
Student > Ph. D. Student 1 8%
Researcher 1 8%
Other 0 0%
Unknown 5 42%
Readers by discipline Count As %
Computer Science 4 33%
Unspecified 2 17%
Medicine and Dentistry 1 8%
Unknown 5 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 May 2023.
All research outputs
#15,052,231
of 26,171,302 outputs
Outputs from Frontiers in oncology
#3,914
of 22,919 outputs
Outputs of similar age
#175,130
of 421,688 outputs
Outputs of similar age from Frontiers in oncology
#156
of 1,220 outputs
Altmetric has tracked 26,171,302 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,919 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 421,688 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.
We're also able to compare this research output to 1,220 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.